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Inside-out Ca2þ signalling prompted by STIM1
conformational switch
Guolin Ma1,*, Ming Wei2,*, Lian He1,*, Chongxu Liu3,4,*, Bo Wu3, Shenyuan L. Zhang5, Ji Jing1, Xiaowen Liang1,
Alessandro Senes6, Peng Tan1, Siwei Li7, Aomin Sun2, Yunchen Bi3, Ling Zhong1, Hongjiang Si5, Yuequan Shen7,
Minyong Li8, Mi-Sun Lee9, Weibin Zhou9, Junfeng Wang3,4, Youjun Wang2 & Yubin Zhou1,5
Store-operated Ca2þ entry mediated by STIM1 and ORAI1 constitutes one of the major
Ca2þ entry routes in mammalian cells. The molecular choreography of STIM1–ORAI1
coupling is initiated by endoplasmic reticulum (ER) Ca2þ store depletion with subsequent
oligomerization of the STIM1 ER-luminal domain, followed by its redistribution towards the
plasma membrane to gate ORAI1 channels. The mechanistic underpinnings of this inside-out
Ca2þ signalling were largely undeﬁned. By taking advantage of a unique gain-of-function
mutation within the STIM1 transmembrane domain (STIM1-TM), here we show that local
rearrangement, rather than alteration in the oligomeric state of STIM1-TM, prompts
conformational changes in the cytosolic juxtamembrane coiled-coil region. Importantly, we
further identify critical residues within the cytoplasmic domain of STIM1 (STIM1-CT) that
entail autoinhibition. On the basis of these ﬁndings, we propose a model in which STIM1-TM
reorganization switches STIM1-CT into an extended conformation, thereby projecting the
ORAI-activating domain to gate ORAI1 channels.
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T
-cell receptor engagement by antigens is an instrumental
step in initiating the host adaptive immune response
against invading pathogens1. It triggers a cascade of
signalling events to elicit the inﬂux of extracellular Ca2þ
through the Ca2þ release-activated Ca2þ (CRAC) channel, a
classical example of store-operated calcium entry (SOCE) that is
mediated by the stromal interaction molecule 1 (STIM1) and
ORAI1 (ref. 2). Aberrant STIM–ORAI signalling is intimately
involved in the pathogenesis of immunodeﬁciency, cardiac
hypertrophy and cancer metastasis2–6. The dynamic STIM1–
ORAI1 coupling represents a unique inside-out signalling event
that occurs at endoplasmic reticulum (ER)–plasma membrane
(PM) junctions. We and others have previously shown that the
four-pass transmembrane protein ORAI forms the pore subunit
of the CRAC channel7,8 and is directly gated by an ER-resident
Ca2þ sensor protein STIM1 through physical interactions6,9–15.
The major activation steps for SOCE have thus far been
understood at a descriptive level2,5,15. Following store depletion,
the dissociation of Ca2þ from the luminal EF-hand motif induces
dimerization or oligomerization of the STIM1 luminal domain. It
is generally assumed that this switches STIM1 into an extended
conformation, with subsequent migration of STIM1 towards
regions of ER–PM appositions (termed ‘puncta’) to open ORAI1
Ca2þ channels through physical contacts.
Although considerable insight into the STIM–ORAI pathway
has been gained from cellular studies (reviewed in refs 2–5,15),
the mechanistic underpinnings of this inside-out Ca2þ signalling,
particularly the crucial questions of how ER-luminal signals are
transmitted towards the STIM1 cytoplasmic domain (STIM1-CT)
and how the STIM1 juxtamembrane coiled-coil region (CC1)
interplays with the ORAI-activating domain (CAD/SOAR)9,10,
have not been addressed. This is largely because of the technical
difﬁculty in capturing and stabilizing resting and activated STIM1
in a membrane-like environment in vitro, and the lack of robust
assays to visualize the CC1–SOAR interaction at real time under
physiological conditions. Here we have adopted a ‘divide-to-
conquer’ strategy with a focus on the interplays among the single
transmembrane domain of STIM1, the juxtamembrane cytosolic
coiled-coil (CC1) region and the minimal ORAI1-activating
domain CAD/SOAR9,10. We overcome the ﬁrst hurdle by taking
advantage of a previously unrecognized ‘gain-of-function’
mutation within the single transmembrane domain of STIM1
(STIM1-TM) and reconstitution of STIM1-TM into bicelles/
nanodiscs that are compatible with a variety of biophysical assays.
We show, ﬁrst, that the mutant C227W represents STIM1
in one of its activated states, which enables us to probe the
conformational changes within the transmembrane domain both
in vitro and in vivo. With chemical cross-linking and high-
resolution nuclear magnetic resonance (NMR), we pinpoint
critical residues involved in the reorganization of STIM1-TM
during its activation. Next, we show that local rearrangement,
rather than alterations in the oligomeric state of STIM1-TM,
is sufﬁcient to prompt conformational changes in the
juxtamembrane CC1 region. As a consequence, CC1 adopts a
more extended conformation and assumes more helical contents
presumably by forming a stabilized coiled coil. To tackle the
second obstacle, we have devised a novel ﬂuorescence resonance
energy transfer (FRET)-based assay to monitor the dynamic
CC1–SOAR interaction under physiological conditions. The two-
component FRET system affords a real-time visualization of
CC1–SOAR interaction, as well as the ‘tug-of-war’ between CC1
and ORAI1 in living cells. This robust assay also opens a new
avenue to ﬁne-map the CC1–SOAR contact sites, which keeps
SOAR quiescent at rest. Overall, our study provides important
mechanistic insights into a conformational switch model of
SOCE.
Results
Identiﬁcation of new gain-of-function mutations in STIM1-TM.
Ca2þ inﬂux through the ORAI1 channel is often conveniently
triggered through passive store depletion with thapsigargin (TG)
or the Ca2þ ionophore ionomycin in model cellular systems such
as HeLa or HEK293 cells16. However, mutations causing loss of
Ca2þ -sensing capability (for example, D76A)17 or perturbing the
structural integrity of the cytosolic domain (for example, L251S
and R304W)18,19 can bypass this manipulation and cause
constitutive STIM1 puncta formation and Ca2þ inﬂux through
CRAC channels. These types of ‘gain-of-function’ mutations are
thought to largely represent activated conformations of STIM1, but
the existence of such mutations in the STIM1 transmembrane
domain has yet to be explored. Given this unique structural and
functional feature, we set out to screen constitutively activating
mutations throughout STIM1-TM by taking a tryptophan-
scanning approach20,21, with the hope of introducing steric
hindrance at the contact interface to affect STIM1-TM helix
packing and thus cause functional abnormality. Our efforts
led to the discovery of at least two previously unrecognized
‘gain-of-function’ mutations (that is, I220W and C227W),
both of which could be mapped to the same side of a projected
STIM1-TM helical wheel (Fig. 1a,b). These mutations did not
seem to alter Ca2þ release from ER stores or the second phase of
Figure 1 | Identiﬁcation of novel gain-of-function mutations within STIM1-TM. (a) Ca2þ inﬂux in HEKORAI1-CFP stable cells expressing WTand mutant
STIM1-TM constructs (n¼ 30–60) monitored by Fura-2 ﬂuorescence ratio. Store depletion was induced by 2.5mM ionomycin. Shown are representative
traces from three independent experiments. The solid bar above the curves indicates 1mM Ca2þ in the external medium. (b) Effects of tryptophan
substitution of STIM1-TM residues on constitutive Ca2þ entry in HEK ORAI1-CFP stable cells. The level of constitutive Ca2þ entry (n¼ 3) was quantiﬁed
as the difference of mean Fura-2 ﬂuorescence ratio between the peak value in the presence of 1mM Ca2þ and the basal value without externally added
Ca2þ . The size of letters beneath the x axis represents the probability of conserved residues at each position across species including humans,
mice, worms and ﬂies. Inset, helical wheel projection of an ideal STIM-TM helix. (c,d) Confocal images of footprint of HeLa cells co-transfected with
mCherry-ORAI1 and WT (c) or C227W-EGFP-STIM1 (d) constructs. Thapsigargin (TG), 1 mM, was added to trigger store depletion. Scale bar, 5 mm.
(e–g) Constitutive activation of CRAC channels by overexpression of STIM1-C227W. (e) Two representative time courses of normalized inward currents
(pA/pF), measured at  100mV in HEK293 cells co-expressing ORAI1þWT STIM1 (blue) or ORAI1þ STIM1-C227W (red), respectively. Strongly
pre-activated CRAC currents were observed in the cells transfected with ORAI1þ STIM1-C227W. (f) Corresponding leak-subtracted I–V curves taken from
the break-in time points (t¼0 s). (g) Normalized break-in currents averaged from cells transfected with ORAI1þWT STIM1 (n¼ 5) or ORAI1þ STIM1-
C227W (n¼6). (h) Confocal images of GFP-NFAT1 stable HeLa cells (left panels) transiently transfected with WT (right panel, top) or C227W (right
panel, bottom) CFP-STIM1 constructs without store depletion. Note that cells expressing CFP-STIM1-C227W (arrow), but not WT CFP-STIM1, led to
constitutive GFP-NFAT nuclear translocation. Scale bar, 5 mm. (i) Quantiﬁcation of NFAT-dependent luciferase activity in HEK293T cells or Jurkat
(NFAT-Luc) cells transfected with WTor C227W STIM1 constructs. PMA, phorbol 12-myristate 13-acetate. **Po0.01, ***Po0.001, Student’s T-test. Error
bars in all panels are deﬁned as s.e.m.
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ionomycin-triggered Ca2þ inﬂux in the typical ‘Ca2þ add-back’
experiment22 (Fig. 1a; Supplementary Fig. 1a,b). The gain-of-
function phenotype, albeit at varying degrees of constitutive
activation, could also be recapitulated by substituting C227 with
several other amino acids, including asparagine, glutamine,
histidine, glutamate, tyrosine and aspartate (Supplementary
Fig. 1c), or in HEK293 cells without overexpression of ORAI1
(Supplementary Fig. 1d). Since C227W exhibited the highest
potency to elicit constitutive Ca2þ inﬂux, we focused our
following experiments on this unique mutation.
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To unequivocally conﬁrm the ‘gain-of-function’ phenotype
of C227W, we examined the behaviour of this mutant in the
context of several critical steps of the Ca2þ /nuclear factor of
activated T-cell (NFAT) signalling pathway2. Compared with
wild type (WT), STIM1-C227W formed puncta at resting
condition (Fig. 1c,d) and elicited constitutive Ca2þ
inﬂux through CRAC channels as reﬂected by spontaneous
development of CRAC currents (ICRAC) without store depletion
(Fig. 1e–g). Notably, STIM1-C227W expression prompted
NFAT translocation from the cytosol to the nucleus (Fig. 1h)
and further induced NFAT-dependent expression of luciferase in
both HEK293T cells and Jurkat T cells without store depletion
(Fig. 1i). Thus, C227W represents an activated state of
STIM1 and is well suited to serve as a unique molecular tool to
dissect the activation steps of SOCE by circumventing direct
disruption of structural integrity of the luminal domain or the
cytoplasmic domain.
One notable feature of STIM1-TM is the presence of three
glycine residues with small side chains. Glycine residues within a
transmembrane domain often participate in close helix–helix
packing or the introduction of kinks23. We reason that small-to-
large substitution of multiple glycines in STIM1-TM would
impact its structural rearrangement and thus compromise its
normal activity. Indeed, replacement of three glycines or G223/
G225 by tryptophans signiﬁcantly reduced SOCE (Supplementary
Fig. 1e). Together single or multiple mutations within STIM1-TM
could lead to either gain-of-function or hypomorphic phenotypes,
prompting us to further dissect how structural changes in STIM1-
TM facilitate the signal transduction from the ER lumen to the
cytoplasm.
STIM1-C227W prompts structural reorganization of STIM1-TM.
To examine how the activating mutation affects the oligomeric
state of STIM1-TM, we compared the molecular mass between
recombinant WT and C227W in the context of TM-CC1
(residues 209–310) by size-exclusion chromatography coupled
with multi-angle laser light scattering. Both WT and C227W eluted
in sizes comparable to dimer under our conditions in vitro
(Fig. 2a; Supplementary Fig. 2a). Clearly, this result provides strong
evidence arguing against the possibility of a monomer-to-oligomer
transition within the transmembrane domain when STIM1 switches
into an activated status. Nonetheless, since the recombinant
proteins only contain the TM-CC1 region, it does not exclude the
involvement of other regions (for example, EF-SAM or CAD/
SOAR) in driving the formation of higher-order oligomerization
during STIM1 activation. Next, we carried out high-resolution
NMR studies on bicelle-reconstituted STIM1-TM to pinpoint
residues that undergo substantial structural changes during
STIM1 activation, which will be very likely reﬂected in the
chemical shift perturbation. We found that residues including
G225, G226, W228, Q233 and N234 displayed signiﬁcant
resonance changes when STIM1 adopted an activated conformation
(Fig. 2b).
To further reveal potential conformational changes within
STIM1-TM, we decided to use the substituted cysteine-scanning
approach coupled with copper–phenanthroline (CuP) cross-
linking across the predicted STIM1 transmembrane domain, an
assay that we previously developed to probe the ORAI1 pore
architecture13. This method proves to be a convenient and
reliable way to dissect inter-subunit contacts and probe
conformational changes in transmembrane helices. The changes
a b
c d
1.0
0.5
0.0
0.0
1.0
0.5
4
C227W
110
WT (STIM1209–237)
15
N
 (p
.
p.
m
.) 115
120
125
130
10
155
Resting Resting
Resting
Resting C
ro
ss
-li
nk
in
g 
ef
fic
ie
nc
y 
(%
)
Activated
Activated
Activated
Time
(min) 0 15 15
20
25
37
50
75
100
100
80
60
40
20
0 150 150 150
0
** **
C227
C227 I220C F229C
C227
C227W
W228
W228
G226
G223 G225
Q233
N234
N209
I220C F229C MW (kDa)
9
1H (p.p.m)
8 7
8
1
1
12
10
100
10
100
16 20
WT
C227W
N
or
m
a
liz
e
d
a
bs
or
ba
nc
e 
(28
0 n
m)
Elution volume (ml)
M
ol
ec
ul
ar
 m
as
s 
(kD
a)
Figure 2 | Structural changes of STIM1-TM domain upon activation. (a) SEC-MALLS proﬁles of WT (blue, resting) or C227W (red, activated state)
TM-CC1 (STIM1209–310) proteins. The recombinant protein migrated as a single symmetric peak with the plotted molecular size referring to the axis
at the right. Both proteins (MWtheoretical: 21 kDa; MWexperimental: 49B50 kDa) were N-terminally fused with a monomeric GB1 tag to aid puriﬁcation.
(b) Superimposed 15N–1H HSQC spectra of WT (blue) and C227W (red) STIM1-TM (residue 209–237) reconstituted into bicelles. Grey box,
representative residues undergoing chemical shift changes between the resting (WT) and activated (C227W) conformations. (c,d) CuP-catalysed cross-
linking of selected TM-CC1 monocysteine variants. (c) Disulﬁde cross-linking is reﬂected as a dimer band (arrow) on the non-reducing SDS–PAGE. (d) Bar
graph shows the cross-linking efﬁciency of STIM1-TM monocysteine variants (n¼ 3). **Po0.01, Student’s T-test. Error bars in panels are deﬁned as s.e.m.
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in cross-linking efﬁciency could arise from distance change due to
helical swivelling or relative movement towards one another. We
applied this chemical cross-linking approach to compare the
conformations of STIM1-TM at resting or activated states. Since
unambiguous analyses of cross-linking patterns require a
cysteine-less background with subsequent introduction of
monocysteine at each position along STIM1-TM, we used
C227S to mimic the WT-like resting state, given their similarity
in side-chain size and polarity, while C227W represents an
activated status of STIM1-TM. Prior to cross-linking, the
monocysteine mutants predominantly migrated as a single band
corresponding to the size of the monomer on non-reducing SDS–
polyacrylamide gel electrophoresis (PAGE) (Fig. 2c,d). Upon
addition of CuP, recombinant STIM1-TM proteins displayed a
second band, indicating cross-linking of disulﬁde bonds. The
cross-linking data suggest that STIM1-TM possesses two distinct
segments with varying conformational ﬂexibility. In the
C-terminal region, the cross-linking efﬁciency is generally
high at all positions, possibly due to ﬂexibility induced by the
multiple glycine residues and likely enhanced in a detergent
environment. The cross-linking pattern displays a periodicity
that is consistent with the periodicity of an ideal a-helix. A230C,
C227, G226C and I222C exhibited over 70% disulﬁde bond
formation (Supplementary Fig. 3a), suggesting that these
positions are probably located at the dimer interface. By
contrast, the N-terminal segment of STIM1-TM (residues
214–220) displayed markedly lower cross-linking efﬁciency
(Supplementary Fig. 3a). This may indicate that the helices of
the STIM1-TM dimer interact prevalently through the C-terminal
positions, and that a wide crossing angle of the two helices might
splay the N-terminal positions apart. This conformation is
consistent with a computational model of the STIM1-TM
dimer obtained with the program CATM19, which predicts that
STIM1-TM is compatible with a GASright dimer, a frequent
structural motif in membrane proteins mediated by GxxxG-like
sequence patterns24 (in the case of STIM1, the dimer is predicted
to be mediated by S219xxxG223xxxC227, Supplementary Fig. 3b).
Compared with C227S variants, at least two monocysteine
variants (for example, I220C and F229C) in the cysteine-less
background of STIM1-TM-C227W displayed signiﬁcant changes
in the cross-linking efﬁciency (Fig. 2c,d). Thus, we conclude that
STIM1-TM undergoes structural rearrangements when adopting
an activated conformation.
We sought further conﬁrmation that STIM1-TM undergoes
conformational change with another independent assay in vitro.
We introduced donor and acceptor ﬂuorophores at either end of
the dimeric STIM-TM through speciﬁc labelling at a single
cysteine (that is, position F214C or N234C). We then compared
the FRET signals at these two positions between the resting and
activated states. After switching to an activated conformation as
exempliﬁed by C227W, we observed an increase in the FRET
signal (Fig. 3a–f), suggesting a closer spatial proximity of the
donor and acceptor at both the N- and C-terminal end of STIM1-
TM. This was further conﬁrmed through parallel cellular FRET
assays by fusing cyan ﬂuorescent protein (CFP) or yellow
ﬂuorescent protein (YFP) to each end of the STIM1 transmem-
brane domain (Fig. 3g–l). The activating mutant C227W
displayed signiﬁcantly higher FRET signals than WT, thus
reinforcing the conclusion that both ends of STIM1-TM
approach closer in space or undergo helical rotations in response
to STIM1 activation.
STIM1-TM reorganization causes conformational changes in CC1.
The above ﬁndings led us to explore the conformational switch
hypothesis that STIM1-TM reorganization might prompt further
conformational changes in the cytosolic juxtamembrane region5.
We therefore extended our studies from STIM1-TM to encompass
the juxtamembrane coiled-coil region (TM-CC1). Compared with
WT TM-CC1, the activating mutant C227W showed B12%
increase in the overall helical content (Supplementary Fig. 2b,c) in
the secondary structure. The helical structure change could be
attributed to the CC1 region, since the secondary structures of
STIM1-TM in resting or activated states remain unaltered
(Supplementary Fig. 2d). These results are in agreement with our
previous ﬁnding that bringing the N termini of CC1 together
through forced cross-linking led to increased helicity in CC1,
presumably due to the formation of coiled coil in the initial region
of CC1 (ref. 6).
To more faithfully mimic its behaviour in a membrane-like
environment, recombinant TM-CC1 protein was incorporated
into nanodiscs, in which islands of lipid bilayer are surrounded by
a belt of engineered apolipoprotein A1 protein (Supplementary
Fig. 4a)25. We decided to use the Tb3þ -acceptor luminescence
resonance energy transfer (LRET), a sensitive assay that we have
successfully applied to estimate the head-to-end distance of
STIM1-CT6, to reveal conformational changes that might be
reﬂected in the relative distance change between the lipid bilayer
and the C terminus of CC1. TM-CC1 nanodisc with donor alone
exhibited the characteristic emission spectrum of excited Tb3þ
(Fig. 3m–o). TM-CC1 nanodisc with both donor and acceptor
displayed an additional emission peak with the maximum at
B520 nm, indicating the energy transfer from the donor Tb3þ to
the acceptor FITC residing on the nanodisc (Fig. 3m–o). By
contrast, the gated spectrum of TM-CC1-C227W nanodisc
showed a relatively lower emission peak centred around
520 nm. To exclude potential bias introduced during LRET
measurements, we subsequently swapped the position of the
donor–acceptor pair (Supplementary Fig. 4b). Again, we noticed
a reduction of FRET signals in TM-CC1-C227W nanodisc with
diminished acceptor emission and concomitant increase in donor
emission. Collectively, results from these two complementary
assays suggest that STIM1-CC1 adopts a more extended
conformation possibly by gaining more helical content and
reorienting its C terminus away from the ER membrane following
apposition of the N termini of STIM1-CT induced by STIM-TM
rearrangement.
L258-L261 in CC1 is critical for its docking with SOAR. The
next question we asked is how extended CC1 affects the activity of
the ORAI-activating SOAR/CAD domain. There is a tacit belief
that SOAR/CAD is kept quiescent at rest but will be activated to
engage ORAI1 channels following store depletion2–6. Although
we had previously demonstrated the physical interaction between
recombinant CC1 and SOAR6 and determined the CC1–SOAR-
binding afﬁnity in vitro (KD¼ 9.4 mM, Supplementary Fig. 2g),
the underlying structural determinants remain elusive. To solve
this puzzle under physiologically relevant conditions, we
developed a FRET assay by fusing donor or acceptor ﬂuoro-
phores to two autonomous components of STIM1 (Fig. 4a). This
two-component system affords the ﬁrst real-time visualization
of CC1–SOAR/CAD interaction, as well as dissociation induced
by store depletion and the ‘tug-of-war’ between CC1 and endo-
genous ORAI1 (Fig. 4; Supplementary Fig. 5; Supplementary
Movies 1–4). Under resting condition, isolated SOAR/CAD was
tightly tethered against the ER membrane in cells expressing
STIM11–310 (Fig. 4a) or STIM11–342 (Supplementary Fig. 5c), and
exhibited an ER-like tubular distribution pattern. Moreover,
overexpression of STIM11–310 led to a signiﬁcant suppression of
SOAR-induced constitutive Ca2þ inﬂux (Fig. 4d,e). Following
store depletion, the majority of SOAR/CAD was dispersed into
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the cytosol, thus resulting in a remarkable drop in FRET signals
and enabling its subsequent interaction with ORAI1 (Fig. 4a–c;
Supplementary Fig. 5c; Supplementary Movies 1 and 2). By
contrast, SOAR/CAD displayed an even cytosolic distribution
regardless of the ER Ca2þ ﬁling status in cells expressing the
activating mutant STIM11–310-C227W (Fig. 4a–c; Supplementary
Movie 3).
The substantial FRET signal change provides an excellent
opportunity for us to unambiguously map out the minimal region
within CC1 essential for SOAR docking. Through a series of
deletion and mutagenesis studies, we narrowed down the possible
SOAR-interacting site to residues 255–265 with complementary
FRET (Fig. 4f–i), colocalization assays (Supplementary Figs 5 and
6), in vitro pull-down (Fig. 4j and binding assays (Supplementary
Fig. 2g)). In particular, residues 258–261 are crucial for the
CC1–SOAR interaction, since CC1–SOAR interaction was
severely compromised with the deletion of residues 259–263, or
with the introduction of mutations L258G or L261G (Fig. 4h,i;
Supplementary Fig. 6a,b). Substitution of leucine with alanine at
position 258, which presumably would retain the helical
propensity, also led to a signiﬁcant decrease in the FRET signals
at rest (Supplementary Fig. 7a). These mutant constructs caused
spontaneous puncta formation (Supplementary Fig. 6c) and
constitutive Ca2þ inﬂux in HEK293 cells (Fig. 4k,l).
SOAR but not D-SOAR forms heteromers with STIM1–442. By
slightly modifying the donor/acceptor pairs in the FRET assay, we
were also able to further dissect the molecular determinants
within SOAR that govern its docking to CC1 (Fig. 5). We ﬁrst
characterized the oligomeric status of 1–342 and 1–442
in vitro. Elution proﬁles from size-exclusion chromatography
(Supplementary Fig. 8a,b) and gel electrophoresis on native
PAGE (Supplementary Fig. 8c) suggested that both proteins
predominately existed as a dimer, regardless of the presence
or absence of Ca2þ . Our attempts to capture the 1–342/SOAR or
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1–442/SOAR complexes in vitro were not successful, because the
dimeric SOAR tends to fall apart and only stays as a monomer in
the presence of detergents (dashed line, Supplementary Fig. 2f),
the latter of which is required to keep 1–342 or 1–442 soluble and
stable in aqueous solution. We then compared the docking
behaviour of isolated CAD/SOAR domain and D-SOAR (two
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copies of SOAR covalently linked in tandem) toward 1–342 or
1–442 in the cellular FRET assay (Fig. 5a–f). We found that the
isolated CAD/SOAR domain docked tightly to STIM11–442
regardless of the ﬂuctuation of ER Ca2þ (Fig. 5c,d;
Supplementary Fig. 9), a phenomenon that can be attributed to
the formation of stable SOAR heteromers. To the contrary,
D-SOAR failed to associate with STIM11–442, a construct that
contains an intact SOAR domain by itself, but it still retained the
ability to interact with STIM11–342 (Fig. 5e,f, blue line) or the
further truncated variant STIM11–310 at resting conditions
(Supplementary Fig. 10). This ﬁnding strongly implicates that
SOAR may function in a dimeric form since only isolated SOAR
domain, rather than the concatemeric D-SOAR, is capable of
forming a heteromeric complex with the CAD/SOAR fragment in
the context of STIM11–442 (Fig. 5b). This argument is further
corroborated by our ﬁnding that truncation of a region (344–349)
involved in SOAR dimerization or introduction of double
mutations L347A/Q348A in this region10,26 led to failure of YFP-
SOAR docking towards CC1 in the contexts of STIM11–342 or
STIM11–442 (Supplementary Fig. 9b,c).
Mapping residues critical for the CC1–SOAR association. In an
attempt to map the critical residues in SOAR for its association
with CC1, we focused on the two long helices (Sa1 and Sa4,
Fig. 5k,l) in SOAR that have high potential to form coiled coils.
Mutations in the Sa1 helix (382KIKKKR3874QIQQQQ, termed
5KQ) failed to abolish CC1–SOAR interaction (Fig. 5g,h). Notably,
5KQ mutations are known to abrogate the coupling of SOAR to
ORAI1 channels27,28. Thus, the CC1 contact sites within SOAR are
likely distinct from its binding sites with ORAI1. Nonetheless,
residues L416, V419 and possibly L423 within the Sa4 helix
seemed to be crucial for CC1–SOAR interaction, since disruption
of coiled-coil formation through substitution with glycine
(Fig. 5g,h) or alanine (Supplementary Fig. 7a) at these positions
caused dissociation of SOAR/CAD from CC1, spontaneous STIM1
puncta formation (Supplementary Fig. 9e) and constitutive Ca2þ
inﬂux (Fig. 5i,j). All these mutations did not seem to perturb the
dimerization of SOAR by judging from their capacity to interact
with STIM11–442 through heterodimerization (Supplementary
Fig. 9d) and from the in vitro gel ﬁltration elution proﬁles
(Supplementary Fig. 2f). To conclude, results from our FRET and
colocalization assays unveiled an additional possible CC1–SOAR
contact site that requires coiled-coil interplays between the
predicted Ca1 and Sa4 helices (Fig. 5k,l). Notably, this new site
is distinct from the previously reported inhibitory helix spanning
the distal regions of CC1 (residues 310–337), which is suggested to
interact with the ﬁrst helix of SOAR (Sa1 helix)26,29.
Discussion
To date, a number of studies on STIM1 have been directed
exclusively towards either the luminal domain or the cytoplasmic
domain (STIM1-CT) (reviewed in refs 5,15). Although these
studies have at large resolved how the STIM1 luminal domain
senses Ca2þ depletion and how STIM1-CT gates ORAI1
channels, they yielded little or no information regarding
how the signal is initially transduced from ER lumen to the
cytosol. We recently showed that close apposition of STIM1 at
residue 233—the position where the transmembrane domain
(STIM1-TM) ends and the cytosolic portion of STIM1 emerges
from the ER membrane—could switch STIM1 to adopt an
activated conformation to open ORAI1 Ca2þ channels6,30. This
points to a potential role of the rearrangement of the single
transmembrane domain of STIM1 in propagating the
conformational changes towards the cytoplasm. However,
mechanistic dissection of the role of STIM1-TM in mediating
ER lumen-to-cytosol signal transduction has been hindered due
to complications associated with dimerization/oligomerization of
both the ER-luminal and the cytoplasmic domains. Here we take
advantage of a gain-of-function mutation (that is, C227W) in
STIM1-TM to overcome this hurdle. This unique mutant enables
us to dissect the activating mechanism of STIM1 by bypassing
store depletion and dimerization/oligomerization of the EF-SAM
luminal domain31,32 and the CAD/SOAR domain9,10. It is
generally accepted that CAD/SOAR or other STIM1-CT
fragments assemble as a dimer/oligomer regardless of store
depletion9–11,13,26,28,29,33, which makes it very challenging to
examine the oligomeric state and conformations of the single
transmembrane segment per se using full-length STIM1. By
contrast, C227W allows us to uncouple distinct activation steps
and compare the STIM1-TM conformational states without
perturbing the structural integrity of other functional
components. This gain-of-function mutant seemingly resembles
an activated state of full-length STIM1 in several aspects: ﬁrst,
based on our cross-linking and FRET measurement results,
C227W brings the N terminus of STIM1-TM in a shorter
distance, which likely reﬂects the impact of Ca2þ -induced
dimerization/oligomerization of EF-SAM on STIM1-TM31,32;
second, both the C227W substitution and store depletion can
substantially reduce the CC1–SOAR interaction to similar levels
in our FRET assay; third, C227W recapitulates the hallmark
physiological responses in the Ca2þ /NFAT pathways following
store depletion. Together, this unique mutant is suited to answer
questions that are almost intractable with other gain-of-function
mutations found in either the luminal or the cytoplasmic
domains of STIM1. For instance, it enables us to compare the
resting state and one type of activated state of STIM1-TM with
high-resolution NMR and chemical cross-linking, and more
importantly, to further address how luminal signals can be
transmitted through STIM1-TM to propagate conformational
changes throughout the STIM1 cytoplasmic domain. However,
we are aware that C227W may not fully mimic the native Ca2þ -
depleted state of STIM1. For example, the resting FRET signal of
C227W is slightly higher than Ca2þ -depleted WT following
ionomycin treatment in HEK293 cells co-expressing WT or
C227W STIM11–237-CFP/YFP (Fig. 3k,l). In addition, ionomycin
evokes a further increase of FRET in C227W, whereas one would
expect no signiﬁcant FRET changes if C227W is identical to the
Ca2þ -depleted state. We speculate that further oligomerization
of STIM1, possibly working through the EF-SAM domain or
other regions downstream of the SOAR domain, may account for
the observed increase in FRET signals upon addition of
ionomycin to the mutant C227W.
With a combined use of biochemical, spectroscopic and
computational approaches, we have clearly demonstrated that
STIM1-TM undergoes structural reorganization when switching to
an activated state. Our chemical cross-linking results and
computational modelling of STIM1-TM (Supplementary Fig. 3)
indicate that the helices of the STIM1-TM dimer interact primarily
through the C-terminal positions (residues 221–232), and that a
crossing angle of the two helices might separate the lower half of
STIM1-TM (residues 214–220) apart. When adopting an activated
conformation, it is possible that a reduction of the crossing angle
(which is predicted to be over 45 in the computational model of
the resting state, Supplementary Fig. 3b) may bring both helical
ends closer together. Indeed, we have found that I220 and F229 (or
F214 and N234), which are situated below or above the crossing
point, exhibit a similar increase in cross-linking (or FRET)
efﬁciency when STIM1-TM assumes an activated conformation.
The molecular determinants that govern STIM1 autoinhibition
have been a matter of debate. The idea of STIM1 intramolecular
trapping was initially pioneered by Korzeniowski et al.28, who
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proposed that an acidic sequence in CC1 (318EEELE322) could
interact with a basic segment of STIM1-CT (382KIKKK386 in
CAD/SOAR). Although the contact sites proposed are in conﬂict
with recently published structural evidence26,29, the notion of
intramolecular switching during STIM1 oligomerization has been
well accepted. In two subsequent studies6,18, both cellular FRET
and our in vitro LRET assays conﬁrmed the conformational
change in activated STIM1 in the context of STIM1233–474
(ORAI1-activating small fragment or OASF) or STIM1233–685.
Mutations predicted to disrupt coiled-coil formations in CC1 (for
example, L248S or L251S) switch OSAF or STIM1-CT into
extended conformations, pointing to the possibility that the lower
region of CC1 is a key molecular determinant mediating STIM1
activation. In the current study, we have further applied a two-
component FRET assay to monitor the dynamic CC1–SOAR
interaction under physiologically relevant conditions with
minimal structural perturbation on CC1 or SOAR. Through a
series of carefully designed deletion and mutagenesis studies, we
mapped out a minimal region and critical residues that keep
SOAR quiescent at rest. In our mapping strategy, we have kept
one component (CC1 or SOAR) intact while introducing deletion
or point mutations into the other functional domain. Very
recently, Fahrner et al. have applied a method called FRET-
derived interactions in a restricted environment (termed FIRE) to
dissect the coiled-coil interplays in STIM1-CT by artiﬁcially
fusing different short peptide fragments derived CC1 and SOAR
to the STIM1 transmembrane helix via a ﬂexible 32-glycine
linker34. Both studies reached the conclusion that the CC1-a1
helix and the CC3 (or SOAR-a4 helix) are critical for keeping
STIM1 quiescent at rest, but they disagreed in the locations of
speciﬁc CC1–SOAR contact sites. For example, we proposed that
L258/L261 are crucial residues in CC1 involved in docking to
SOAR while Fahrner et al. claimed L251. In our serial deletion
study, we clearly show that C-terminal truncation up to L258/
L261 or L4G substitution at these two positions substantially
weakened the CC1–SOAR interaction. It is anticipated that
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adopts a folded-back conﬁguration that keeps itself inactive through the physical interaction between CC1 and SOAR (Ca1:Sa4 and Ca3:Sa1 coiled-coil
interplays). Upon ER Ca2þ store depletion, dissociation of Ca2þ from the EF-SAM domain initiates a destabilization-coupled oligomerization process in
the ER lumen. Conformational changes in the canonical EF-hand Ca2þ -binding motif disrupt the intramolecular interaction between the EF-hands and SAM
domains, thereby causing aggregation of the luminal EF-SAM domains. The luminal domain oligomerization further triggers structural rearrangement in the
transmembrane domain (STIM1-TM), leading to a closer apposition of the C-terminal end of STIM1-TM. This further propagates conformational changes
throughout STIM1-CT by inducing undocking of SOAR from CC1. STIM1-CT redeploys itself and adopts a more extended conformation by exposing the
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and directly gates ORAI1 channels possibly through direct physical contacts with both termini of ORAI1. This process is likely facilitated by the interaction
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inﬂux through ORAI1 channels activates downstream effectors such as calcineurin, a Ca2þ -dependent phosphatase that dephosphorylates the nuclear
factor of activated T cells (NFAT) and triggers the nuclear translocation of NFAT to regulate gene expression during lymphocyte activation. Ultimately,
activated Tcells differentiate into various effector cells, including Th1, Th2, Th17 and iTregs. The relative positioning and orientation of functional domains in
activated STIM1 remains unknown. The oligomeric states and structures of the luminal EF-SAM domain and of CAD/SOAR, surface rendered as solid
dimers, have not been determined in activated STIM1.
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critical residues identiﬁed through the FIRE assay (that is, L251S,
two-to-three turns below L258/L261 in an ideal helix) would
exhibit similar effects (Supplementary Fig. 7b), because sabotage
at the ‘foundation’ of the CC1 core region would certainly
damage the SOAR-docking sites located above. Admittedly, since
both studies are based on inferences from FRET data without
structural validation, we do not exclude the possibilities that other
regions in SOAR (for example, predicted CC2, residues 353–388,
which has not been examined in our assay) could directly or
indirectly contribute to its association with CC1.
The recently published solution structure of a STIM1-CT
fragment (residues 312–387) shows two extended helices
corresponding to the distal region of CC1 (residues 313–340)
with CC2 (equivalent to SOAR-a1 helix) that are connected by a
short loop (residues 341–343)29. Two U-shaped monomers
assemble into a symmetric antiparallel dimer through extensive
coiled-coil interactions. The potential interaction between the
distal region of CC1 and SOAR is also inferred from the crystal
structure of a portion of Caenorhabditis elegans STIM1-CT,
which shows a segment of CC1 helix docking against the SOAR
domain26. Deletion of the corresponding segment in human
STIM1 resulted in an activated phenotype, thus leading to the
proposal that this region (also termed ‘the inhibitory helix’ or the
IH domain, corresponding to human STIM1310–337) controls the
intramolecular conformational switching of STIM1 (refs 26,35).
Nonetheless, the IH domain probably only reﬂects part of the
CC1–SOAR interaction because L251S, L258G/A or L261G
substitutions in the initial region of CC1 could overcome this
‘inhibitory’ effect. Very recently, a disease-associated mutant
R304W that causes constitutive STIM1 activation has been
reported in patients with the Stormorken syndrome19. Notably,
R304 is located far above the additional SOAR-docking region
(233–261) identiﬁed through our FRET studies. The introduction
of R304W did not affect the interaction between STIM11–310-CFP
and YFP-SOAR (Supplementary Fig. 7b), but it signiﬁcantly
weakened the association of STIM11–342-CFP with YFP-SOAR
(Supplementary Fig. 7c). Hence, R304 is more likely to perturb
the interaction between the distal region of CC1 and SOAR.
Indeed, Morin et al. proposed a model in which R304W disrupts
the electrostatic interaction with E318 and the hydrogen bonding
with Q314, thus distorting the IH domain that is also involved in
locking SOAR in quiescence36. On the basis of these ﬁndings, we
speculate that the inhibitory helix at the distal region of CC1
seems to be critical for anchoring SOAR (Sa4 helix) and the lower
portion of CC1 (Ca1 helix) in a particular orientation that
favours their physical contact, and that deletion or structural
perturbation of this region would impose structural constraints to
prevent SOAR docking towards CC1. However, this hypothesis
warrants further test and ultimate structural validation.
In conclusion, we propose that the single transmembrane
domain of STIM1 has a speciﬁc role other than to simply connect
the luminal and cytoplasmic domains Figure 6. We suggest that it
undergoes structural rearrangement during the ER lumen-to-
cytosol signal transduction, and that reorganized STIM1-TM
prompts a conformation switch in the juxtamembrane CC1
region to release SOAR from contact with a previously
unrecognized docking site in CC1. Overall, our multi-pronged
approach provides physiologically relevant evidence to support
the conformational switch hypothesis during STIM1 activation.
Methods
Chemicals and other reagents. Tetramethylrhodamine (TMR)-5-maleimide,
ﬂuorescein (FITC)-5-maleimide and a-bungarotoxin (BTX) ﬂuorescent conjugate
(Alexa Fluor 555, AF555) were purchased from Life Technologies. Tris(2-carbox-
yethyl)phosphine (TCEP) was obtained from Pierce (Thermo Scientiﬁc).
1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-diheptanoyl-sn-
glycero-3-phosphocholine (DHPC) and ﬂuorescent lipid 1,2-dioleoyl-sn-glycero-
3-phosphoethanolamine-N-(carboxyﬂuorescein) (PE-FITC) were purchased from
Avanti Polar Lipids. Isopropyl-b-D-thiogalactopyranoside (IPTG), copper(II)
sulfate, 1,10-phenanthroline, n-octyl-b-D-glycoside (OG), lauroylsarcosine sodium,
N-ethylmaleimide, ionomycin, TG and phorbol 12-myristate 13-acetate (PMA)
were purchased from Sigma. Isotopes used for labelling recombinant proteins were
from Cambridge Isotope Laboratories. Anti-GFP (sc-8334), anti-YFP (sc-32897,
Santa Cruze Biotech Inc.) and anti-CFP (SAB1100419, Sigma) antibodies were used
at 1:1,000 dilution. All other reagents were purchased from Sigma-Aldrich.
Constructs for ﬂuorescence imaging. Full-length complementary DNAs
(cDNAs) of human STIM1 was subcloned into pCMV6-XL5 (Origene)37 with the
insertion of enhanced green ﬂuorescent protein (EGFP), YFP or CFP between two
additional NarI sites introduced immediately after residue N39. STIM1 mutant
constructs were subsequently made using the QuikChange Lightning site-directed
mutagenesis kit (Agilent). For STIM1-CFP and STIM1-YFP constructs, human
STIM1 was inserted into pECFP-N1 or pEYFP-N1 between XhoI and BamHI.
Truncated STIM1-CFP and STIM1-YFP variants were prepared by standard PCR
and ligation. pCDNA3.1(þ )-mCherry-ORAI1 was made by inserting mCherry
between BamHI and EcoRI restriction sites and human ORAI1 between EcoRI and
XhoI sites (Life Technologies). NFAT11–460-GFP38, mCherry-CAD9, YFP-SOAR10
and YFP-D-SOAR (tandem SOAR domain)39,40 were obtained from Addgene or
generated as previously described.
Constructs for luciferase assays. The full-length cDNA of mouse STIM1 was
inserted into pEF4/myc-His B (Life Technologies) between BamHI and XbaI sites
for luciferase assays. The luciferase reporter pGL4.30[luc2P/NFAT-RE/Hygro] and
the pRL-TK plasmid encoding Renilla luciferase were purchased from Promega.
The luciferase reporter plasmid was further transfected into Jurkat T cells to make a
stable reporter cell line (termed Jurkat-NFAT-Luc).
Constructs for recombinant protein expression in E. coli. The sequence of
TM-CC1 domain (residues 209–310) was ampliﬁed via PCR and cloned into the
pProEX HTb vector (Life Technologies) between the BamHI and XhoI sites for
expression as (His)6-TM-CC1 proteins. In some experiments, the recombinant
STIM1 fragments were fused to the B1 domain of streptococcal protein G (GB1), a
monomeric small tag that proves to increase the solubility without appreciable
perturbation to membrane proteins kept in lipids or membrane mimetics41. (His)6-
TM (residues 209–237) was prepared by introducing a stop codon after residue 237.
Their variants, including C227S, C227W and other monocysteine constructs, were
made using the QuikChange Lightning site-directed mutagenesis kit (Agilent).
To generate GB1-TM-CC1-LBT-(His)6 variants, the cDNA encoding a
lanthanide-binding tag (residues GGFIDTNNDGWIEGDELLLEEG)6 was inserted
downstream of GB1-TM-CC1-His6 via a single XhoI site. To produce high-afﬁnity
peptide (HAP)-fused proteins, a double-stranded oligo encoding the 13-mer HAP
peptide (WRYYESSLLPYPD) was synthesized (Integrated DNA Technologies) and
inserted immediately downstream of residue 310 (termed GB1-TM-CC1-HAP-
His6). The corresponding mutant C227W was generated using the QuikChange
Lightning site-directed mutagenesis kit (Agilent).
The plasmid pMCSG9-SOAR26 was a gift from Dr Yuequan Shen (Department
of Biochemistry and Molecular Biology, Nankai University, Tianjin, China) and the
plasmid pMSP1D1 used to make the membrane scaffold protein for nanodiscs was
obtained from Dr Stephen Sligar (Department of Chemistry, University of Illinois
Urbana-Champaign, Urbana, IL).
Real-time intracellular Ca2þ measurements. Intracellular Ca2þ levels were
measured with Fura-2 AM by following our previous procedures13,14,40,42. In brief,
HEK ORAI1-CFP stable cells cultured on coverslips were kept in a dye-loading
solution (107mM NaCl, 7.2mM KCl, 1.2mM MgCl2, 1mM CaCl2, 11.5mM
glucose and 20mM HEPES–NaOH (pH 7.2)) with 2 mM Fura-2 AM for 30min.
Cells were then kept in Fura-2 AM free solution for another 30min. For cells
transfected with STIM1-activating mutations, 300mM Ca2þ or nominally Ca2þ -
free solution were used to keep cells healthy. Fura-2 signals were recorded using a
ZEISS oberserver-A1 microscope equipped with a Lambda DG4 light source
(Sutter Instruments), Brightline ﬁlter sets (part number: FURA2-C-000, Semrock
Inc.), a  40 oil objective (numerical aperture¼ 1.30) and an iXon3 EMCCD
camera (Oxford Instruments), and the MetaFluor software (Molecular Devices).
Emission ﬂuorescence at 505 nm generated by 340 nm excitation light (F340) and
380 nm light (F380) was collected every 2 s, and intracellular Ca2þ levels are shown
as F340/F380 ratio. All experiments were carried out at room temperature. Traces
shown are representative of at least three independent repeats with each including
30–60 single cells.
Epiﬂuorescence imaging and FRET measurements. The same system used in
Ca2þ measurements plus an Optosplit II Image Splitter (Cairn Research Limited)
was used for FRET measurements. CFP (428.9±5.5Ex/465±32Em), YFP
(502.6±11.2Ex/549±21Em) and FRETraw (428.9±5.5Ex/549±21Em) ﬁlters were
used to capture images (FCFP, FYFP and Fraw, respectively) every 10 s at room
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temperature. Three-channel-corrected FRET was calculated as previously descri-
bed40,42,43. FRET signal was calculated using the following formula:
FRETc¼ Fraw Fd/Dd FCFP Fa/Da FYFP, where FRETc represents the
corrected total amount of energy transfer, Fd/Dd represents measured bleed-
through of CFP into the FRET ﬁlter (0.826) and Fa/Da represents measured bleed-
through of YFP through the FRET ﬁlter (0.048). To reduce variations caused by
differences in expression levels, FRETc values were normalized against donor
ﬂuorescence (FCFP) to generate an N-FRET (normalized FRET) signal. To eliminate
instrument-dependent factors, apparent FRET efﬁciency, Eapp, was calculated using
the following equation: Eapp¼N-FRET/(N-FRETþG)43, where G (4.59) is the
system-dependent factor. It is obtained with partial YFP photobleaching method:
G¼ (FRETc FRETcpost)/(FCFPpost FCFP), where FRETcpost and FCFPpost are
corresponding FRETc and FCFP values after partial photobleach of YFP43. The
intensity of the light used to bleach YFP was carefully chosen so that it will not
bleach CFP at the same time. All ﬂuorescence images were collected and brieﬂy
processed with MetaFluor software (Molecular Devices), and then the resulting
data were further analysed with Matlab R2012b software and plotted with Prism5
software. Representative traces of at least three independent experiments
performed on 15–30 cells are shown as mean±s.e.m.
Electrophysiological measurements. Whole-cell recordings were performed
using transfected HEK293 cells. Brieﬂy, currents were recorded using an EPC-10
Mac-driven patch-clamp ampliﬁer (HEKA Elektronik). All recordings were per-
formed at room temperature. Command voltage protocol generation and data
acquisition were performed using Patchmaster (HEKA Elektronik). The membrane
potential was held at 0mV, and 190-ms voltage ramps from  100 to 90mV were
delivered every 2 s. The standard Csþ -containing pipette solution consisted of the
following (mM): 130 Cs glutamate, 8 NaCl, 0.9 CaCl2, 12 EGTA and 10 HEPES;
pH¼ 7.3, adjusted with CsOH. This solution was supplemented with 10mM
MgCl2 to inhibit the endogenous Mg2þ -inhibited cation (MIC/TRPM7) channels.
The standard extracellular solution contained (mM) the following: 150 Na aspar-
tate, 2 CaCl2, 2 MgCl2, 4.5 KCl and 10 HEPES; pH¼ 7.3, adjusted with NaOH. The
cell capacitance and pipette capacitance were compensated during recording using
the software; series resistance was not compensated. In Fig. 1e–g, the time courses
were not leak-subtracted. The current–voltage (I–V) relationships were corrected
for leakage; the residual currents after 10 mM Gd3þ treatment were considered as
the leak. The HEK cells we used have residual endogenous TRPM7 currents44,
which might account for the outward currents shown in our leak-subtracted,
break-in I–V plot. Data were analysed with OriginPro 8 software (OriginLab) and
are expressed as mean±s.e.m.
Confocal and TIRF imaging. Cell lines used for imaging include HEK293 and
HeLa cells. All cells were grown in DMEM (Sigma) supplemented with 10mM
HEPES and 10% heat-inactivated fetal bovine serum, unless otherwise noted.
Transfections were performed using Lipofectamine 2000 (Life Technologies) fol-
lowing the manufacturer’s protocol. To aid efﬁcient and stable puncta formation,
the DMEM medium was substituted by pre-warmed Ca2þ -free Hank’s balanced
salt solution before imaging. TG (0.5–1 mM) or 2.5 mM ionomycin was used to
induce store depletion. Live cell imaging was performed at room temperature with
 60 oil lens on an inverted Nikon Eclipse Ti-E microscope customized with A1R-
A1 confocal and motorized total internal reﬂection ﬂuorescence (TIRF) modules
using argon-ion (405 and 488 nm) and helium-neon (543 nm) or diode (561 nm) as
laser sources. In some experiments, a Zeiss LSM 700 confocal system equipped with
a  100 oil lens (numerical aperture¼ 1.45) was used to obtain images with higher
resolution. Image analysis was performed using the NIS-Elements software (Nikon)
or Image J (NIH).
NFAT-related assays. For the NFAT nuclear translocation assay, a HeLa cell line
stably expressing NFAT1–460-GFP was established to monitor the cellular locali-
zation of NFAT. Cells were cultured on glass-bottom dishes (MatTek), transfected
with pMCV6-XL5-CFP-STIM1 (WT or C227W) constructs and imaged 24 h post
transfection.
For NFAT-responsive luciferase assay, HEK293T cells were cultured in 96-well
plates and transfected with pEF4/myc-His B-STIM1 (WT or C227W) constructs
and NFAT-luciferase reporter gene pGL4.30[luc2P/NFAT-RE/Hygro] (Promega).
The Renilla luciferase gene (pRL-TK) was also co-transfected as a control for
counting transfected cells and calculating transfection efﬁciency. Jurkat-NFAT-Luc
stable cells were electroporated with pEF4/myc-His B-mSTIM1 (WT or C227W)
plasmids using the Neon transfection system (Life Technologies). Transfected cells
were aliquoted in a 24-well plate in RPMI 1640 medium supplemented with
10% FBS. At 16–18h after transfection, both HEK293T and Jurkat cells were treated
with trace amounts of dimethyl sulfoxide solution (as mock), PMA (1mM) or
PMAþTG (1mM). Cells were harvested after an additional 8 h. Luciferase activity
was assayed using the Dual Luciferase Reporter Assay System (Promega) on a Biotek
Synergy2 luminescence microplate reader. The ratio of ﬁreﬂy to Renilla luciferase
activity was plotted for HEK293T cells and the results for Jurkat cells were
represented as ﬁreﬂy luciferase activity. All the data were normalized against the
mock group.
Recombinant protein expression and puriﬁcation. Escherichia coli strain BL21
(DE3) cells (EMD Millipore) were transformed with plasmids encoding various
STIM1 constructs, and grown at 37 C in LB medium with 100mg l 1 of ampicillin.
Protein expression was induced by the addition of 500mM IPTG when OD600 of the
culture reached 0.6–0.8, followed by incubation for another 3–4h. Harvested cells
were resuspended in a resuspension buffer containing 20mM Tris-HCl pH 7.4,
10mM imidazole, 200mM NaCl, 2mM TCEP and 0.6% N-lauroylsarcosine or 1%
OG, and sonicated. The cellular debris was removed by centrifugation. In the case of
His6-tagged proteins, the lysate was applied to Ni2þ -nitrilotriacetic acid (Ni-NTA)-
agarose resin (Qiagen). Bound recombinant proteins were eluted in 20mM Tris pH
7.4, 250mM imidazole, 150mM NaCl, 1mM TCEP and 0.6% N-lauroylsarcosine
or 1% OG and further puriﬁed by gel ﬁltration on a Superose 6 10/300 GL column
or Superdex 200 10/300 GL column (GE Healthcare).
Nuclear magnetic resonance spectroscopy. His6-STIM1-TM (WT and C227W)
proteins were reconstituted into bicelles for NMR studies. For expression of stable
isotope-labelled proteins, a 5-ml culture was initially grown in LB media at 37 C
overnight. The cells were gently pelleted and resuspended into 500ml M9 minimal
media. The media was supplemented with 15N-NH4Cl, 13C-glucose, 13C/2H-glucose
or D2O (Cambridge Isotope Laboratories), according to standard labelling schemes.
Cultures were further grown until an OD600 of 0.6 before inducing protein
expression with 1mM IPTG at 37 C for 4 h and then were harvested by cen-
trifugation. Cell pellets were resuspended in a buffer containing 20mM Tris pH 8.0,
200mM NaCl, 2mM TCEP and sonicated. His6-TM-CC1 was isolated in an
inclusion body in the absence of appropriate detergents. The supernatant and
inclusion body were separated by centrifugation. The inclusion body was resus-
pended by 20mM Tris-HCl pH 7.4, 10mM imidazole, 200mM NaCl, 2mM TCEP
and 8M urea. The lysate was applied to Ni-NTA resin (Qiagen). Bound recombinant
proteins were eluted in 20mM Tris pH 7.4, 250mM imidazole, 150mM NaCl, 1mM
TCEP and 8M urea. The eluted protein was dialysed to ddH2O to remove urea. The
precipitates were centrifuged and dissolved by TFE in a round-bottom ﬂask mixed
with DMPC and DHPC lipids (Avanti Polar Lipids). A protein to DMPC ratio of
1:100 and a q-factor of 0.25 (the DMPC/DHPC molar ratio) were generally applied.
The mixture was dried to a thin ﬁlm under an N2 stream followed by high-speed
vacuum overnight. The dried ﬁlm was resuspended in a sample buffer solution
(20mM Tris, pH 7.2, 200mM NaCl and 5mM TCEP) and was subjected to repeated
cycles of freeze and thaw until a clear solution was obtained.
All NMR spectra were acquired at 27 C on Bruker Avance 600 and 850-MHz
spectrometers. The acquired data were further processed using the software
package NMRPipe45 and analysed with Sparky46.
Fast protein liquid chromatography. Size-exclusion chromatography coupled
with multi-angle laser light scattering measurements were performed on a GE
FPLC system with a Superdex 200 10/300 GL column (GE Healthcare) and an in-
line eighteen-angle DAWN HELLOS II instrument equipped with an Optilab rEX
Refractive Index Detector (Wyatt Technology) by following previous proce-
dures6,14. Five hundred microlitres of 10–100 mM protein samples were subjected
to chromatography in a buffer consisting of 20mM TrisHCl pH 7.3, 150mM
NaCl, 2mM dithiothreitol and 0.6% N-lauroylsarcosine at a ﬂow rate of
0.3mlmin 1. The protein concentrations were calculated from the absorbance at
280 nm, and the light scattering data were collected at 663 nm. Molecular weight
was calculated using the ASTRA software (Wyatt Technology).
Pull-down assay to probe CC1–SOAR interaction in vitro. In all, 100 ml of
1mgml 1 of MBP (used as negative control) or MBP-SOAR was immobilized on
100 ml amylose resin (New England Biolabs), and incubated for 4 h at 4 C with
each 400 mg of the recombinant CC1 variants in 1ml buffer containing 20mM Tris
pH 7.5, 150mM NaCl and 1mM TCEP (TN buffer), followed by 10-time washing
with the TN buffer to eliminate nonspeciﬁc binding. The resin was mixed with
100 ml TN buffer and 4 SDS gel-loading buffer, heated at 100 C for 10min and
brieﬂy centrifuged prior to gel electrophoresis. Samples were separated on 16%
SDS–PAGE. Bound proteins were visualized on SDS–PAGE after Coomassie
Brilliant Blue R-250 staining.
Copper/phenanthroline-catalysed disulﬁde cross-linking. CuP-catalysed dis-
ulﬁde cross-linking studies were carried out as described previously13. In brief,
1mM CuSO4/3mM 1,10-phenanthroline was added to 50 ml of puriﬁed
recombinant proteins (1mgml 1) in 20mM HEPES pH 7.4, 150mM NaCl and
1mM TCEP. The mixture was incubated on ice for 15min or for the time
indicated. Reactions were stopped by the addition of an equal volume of quenching
solution consisting of 20mM HEPES, 150mM NaCl, 100mM N-ethylmaleimide
and 50mM EDTA, pH 7.4. Samples were mixed with 5 non-reducing SDS
loading buffer, heated at 60 C for 10min and subjected to electrophoresis on 15%
SDS–PAGE or 8–16% NuPAGE (Life Technologies). Each cross-linking
experiment was repeated independently for at least three times. The disulﬁde cross-
linking efﬁciency for each cysteine substitution was determined as the ratio of
dimeric GB1-TM-CC1 to total GB1-TM-CC1 (monomer plus dimer).
Quantiﬁcation of the fraction of GB1-TM-CC1 was performed using the program
Image J (NIH).
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Protein conjugation with dyes. Monocysteine-containing TM-CC1 (on the
background of C227S and C227W) variants were labelled with FITC-maleimide and
TMR-maleimide for FRET measurements. In all, 10–20mM dye stocks were pre-
pared in anhydrous DMF immediately prior to use. A total of 50B100mM protein
samples in 20mM Tris-HCl pH 7.3, 150mM NaCl and 1% OG were ﬁrst treated
with 10mM TCEP to completely break the disulﬁde bonds. Prior to the reaction
with dye, excess TCEP was removed by quickly passing the sample through a PD-10
desalting column (GE Healthcare) and the buffer was exchanged to PBS, 1mM
TCEP and 1% OG. The reactive dye (20-fold molar excess) was added into 50mM of
reduced protein sample in a total volume of B500ml with constant stirring. The
mixture was incubated at room temperature for 2 h or at 4 C overnight with con-
stant agitation. Next, 100mM 2-mercaptoethanol was added to the mixture to stop
the reaction. After labelling, free dye was removed by ﬁrst passing the sample
through Ni-NTA resin and then through a PD-10 column (GE Healthcare). Efﬁ-
ciently labelled protein yielded a B0.8–0.9:1 molar ratio of ﬂuorophore to protein,
based on measuring the absorbance at 492 nm (FITC maleimide, e¼ 83,000M 1
cm 1), 541 nm (TMR maleimide, e¼ 95,000M 1 cm 1; Molecular Probes
Handbook, 11th edition) and 280 nm in 6M guanidine HCl (Pierce) for the protein.
Nanodisc assembly. E. coli strain BL21(DE3) cells (EMD Millipore) were trans-
formed with plasmids encoding membrane scaffold protein 1D1 (MSP1D1) and
grown at 37 C in LB medium with 50mg l 1 of kanamycin. MSP1D1 puriﬁcation
and nanodisc assembly were performed as previously described with slight mod-
iﬁcations6. A ﬂuorescent lipid, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-
(carboxyﬂuorescein) (PE-FITC) is sparsely incorporated into the nanodisc to track
the assembly of nanodiscs, and more importantly, is utilized as a donor in the
FRET assay or acceptor in the LRET assay to examine the distance between the
C-terminal end of assayed recombinant proteins and the lipid bilayer in nanodisc.
In brief, MSP1D1 at 0.1–0.2mM concentration was combined with cholate-
solubilized DMPC and the ﬂuorescent lipid PE-FITC to reach a ﬁnal molar ratio of
1:65:0.5. After incubation at room temperature for 2 h, the self-assembly process is
initiated by incubation with adsorbent Bio-beads M2 (Bio-Rad) for at least 2 h.
Nanodiscs incorporating GB1-TM-CC1-HAP (WT and C227W) or GB1-TM-
CC1-LBT (WT and C227W) were assembled with the MSP1D1:DMPC:target
protein:PE-FITC ratio of 1:65:0.5:0.5. Assembled TM-CC1 nanodiscs were analysed
by gel ﬁltration on a Superose 6 10 300 1 GL column (GE healthcare). Successful
incorporation of TM-CC1 was further conﬁrmed by SDS–PAGE and ﬂuorescence
measurement for each fraction. The plotted ﬂuorescence trace representing
incorporated TM-CC1 overlaid well with the ultraviolet trace (absorbance of
MSP1D1 and TM-CC1) of the assembled nanodiscs (Supplementary Fig. 4).
Luminescence resonance energy transfer assay. LRET assays were performed
on the QuantaMaster 40 spectroﬂuorometer equipped with a pulsed xenon exci-
tation source for phosphorescence lifetime measurement6. In brief, a Tb3þ :protein
ratio of 0.9:1 was adopted. The spectra were collected from 450 to 650 nm with the
excitation set at 280 nm and the slit widths set at 4–6 nm. When acquiring the
luminescence spectra, a gate of 200 ms was set to eliminate ﬂuorescence arising
from directly excited acceptor and scattered light.
Circular dichroism spectroscopy. Circular dichroism spectra of recombinant
proteins were recorded in a Jasco-715 spectropolarimeter at 22 C using a 1-mm
path length quartz cell with the protein concentration at 15–20 mM in PBS con-
taining 1% OG at pH 7.3. All spectra were obtained as the average of at least eight
scans with a scan rate of 50 nm min 1. The ellipticity was measured from 190 to
260 nm and converted to mean residue molar ellipticity (deg cm2 dmol 1 res 1).
Fluorescence spectroscopy. Fluorescence spectra were acquired on a QM40
spectroﬂuorometer (Photon Technology International). To measure inter-subunit
FRET in the context of TM-CC1 with C227S or C227W as background, FITC- or
TMR-labelled monocysteine variants were assayed in PBS, pH 7.3 containing 1% OG
and 1mM TCEP. The ﬂuorescence spectra were recorded from 490 to 650nm with the
excitation set at 475 nm to minimize the directly excited emission from the acceptor.
To enable the FRET measurements between the C terminus of TM-CC1-HAP and the
ﬂuorescent nanodisc, Alexa Fluor 555-labelled b-BTX was mixed with TM-CC1-HAP
(residual BTX removed through gel ﬁltration) to form a stable acceptor complex6,47.
The ﬂuorescence spectra were recorded from 490 to 650nm with the excitation at
475nm in 20mM Tris-HCl, pH 7.3, 150mM NaCl and 2mM TCEP.
Biacore surface plasmon resonance measurements. Biacore surface plasmon
resonance experiments were performed at 25  C on a Biacore 3000 (GE Healthcare
Bio-Sciences AB, Uppsala, Sweden). CC1 sensor surface was prepared using ligand
thiol coupling, with the cysteine residue at the N terminus of CGG-CC1(233–342)
(ref. 6). The immobilization was performed on a CM3 sensor chip at 5 ml min 1
ﬂow rate with PBS (10mM sodium phosphate pH 7.4, 150mM NaCl). Flow cell
was activated with 15ml of EDC/NHS followed by 30ml PDEA (GE Healthcare) to
introduce a reactive disulﬁde group on the surface. Thirty microlitre of CC1
(10 mgml 1 in 10mM sodium acetate pH 5.5) was injected onto the activated
surface and then blocked with 30 ml of cysteine-NaCl. Approximately 650 response
units of CC1 were immobilized. A reference ﬂow cell was prepared with activation
and blocking steps, but without any protein coupled. Binding study was carried out
at 50ml min 1 ﬂow rate using TBS (20mM Tris, pH 7.0, 150mM NaCl)
containing 0.1% BSA (w/v) as running buffer. MBP-SOAR (0–16 mM, 2 dilution)
or MBP stock in TBS was ﬁrst diluted twofold in TBS containing 0.2% BSA, then
further diluted with running buffer and injected onto CC1 and reference surfaces.
Background-corrected sensorgrams were collected and analysed using
BIAevaluation (version 4.1).
Gel electrophoresis with native PAGE. Native PAGE was performed using
4–16% NativePAGE Novex Bis-Tris gels (Life Technologies). Samples were pre-
pared using the NativePAGE Sample Prep Kit (Life Technologies) following the
manufacturer’s protocols. Samples and unstained protein standards (NativeMark,
Life Technologies) were run in cold anode (50mM BisTris, 50mM Tricine, pH 6.8)
and deep-blue cathode buffers (50mM BisTris, 50mM Tricine, pH 6.8 and 0.02%
Coomassie G-250) for 1 h at 150V, whereupon the cathode buffer was replaced
with slightly blue cathode buffer (50mM BisTris, 50mM Tricine, pH 6.8, 0.02%
Coomassie G-250) and electrophoresis continued for 1–2 h at 180V. Following
electrophoresis, gels were stained with Coomassie brilliant blue R-250 or trans-
ferred to polyvinylidene diﬂuoride membranes for western blotting.
Computational modelling of STIM1-TM. The structure of STIM1-TM was pre-
dicted with CATM48. CATM is a program for the structural prediction of GASright
motifs, a common structural motif for transmembrane dimerization characterized
by GxxxG and similar sequence patterns formed by small amino acids separated
(Gly, Ala and Ser) at i, iþ 4 (ref. 24). GxxxG-like motifs are frequently involved in
transmembrane association24, where they allow the formation of networks of
hydrogen bonds between Ca–H donors and carbonyl oxygen acceptors on opposed
helices19. The sequence of STIM1-TM contains two GxxxG-like motifs
(S219xxxG223 and G226xxxA230). CATM is distributed with the MSL software library
v. 1.2 (ref. 49), available at http://msl-libraries.org.
Statistical analyses. Unless otherwise noted, quantitative data are expressed as
the mean and s.e.m. Statistical signiﬁcance was determined with a two-tailed
Student’s t-test. *Po0.05; **Po0.01; ***Po0.001.
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